|
- Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
Preclinical and observational studies suggest that exercise may improve cancer outcomes However, definitive level 1 evidence is lacking In this phase 3, randomized trial conducted at 55 centers,
- Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
Frequency and Relevance of MYD88 L256P Mutation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy , European Journal of Neurology, 32, 8, (2025) https
- Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and . . .
The protocol specified reporting of one-sided P values; in accordance with Journal policy, two-sided P values are reported Analyses were performed with the use of SAS software, version 9 4 The
- Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
In this phase 3b, open-label, controlled trial, adult participants with obesity but without type 2 diabetes were randomly assigned in a 1:1 ratio to receive the maximum tolerated dose of
- Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 . . .
Letter to the Editor: Serum creatinine-to-albumin ratio as a predictor of 28-day mortality in critically ill patients with ischemic stroke: A retrospective cohort study, Journal of Clinical
- Lepodisiran - The New England Journal of Medicine
Elevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease The safety and efficacy of lepodisiran, an extended-duration, small interfering RNA targeting hepa
- Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
Tarlatamab is a bispecific T-cell engager immunotherapy that concomitantly targets delta-like ligand 3 (DLL3), which is expressed on the surface of cancer cells in 85 to 96% of patients with small
- The New England Journal of Medicine | Research Review Articles on . . .
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of
|
|
|